ITI Pharma and Healthcare Fund Regular vs DSP Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹224 Cr | ₹3114 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 18% |
| Expense Ratio | 2.35 | 1.9 |
| Manager | Rohan Korde | Jay Kothari |
| ISIN Code | INF00XX01BL5 | INF740KA1LD8 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | -6.9% | -5.09% |
| 6 Month | -11.9% | -8.15% |
| 1 Year | -4.47% | -3.12% |
| 3 Year | 16.34% | 19.9% |
| 5 Year | - | 14.19% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | -9.06% | -4.06% |
| 1 Year | -16.17% | -4.64% |
| 3 Year | 7% | 12.22% |
| 5 Year | - | 14.7% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 17.33% | 23.57% |
| 3 Year | 19.38% | 21.31% |
| 5 Year | - | 25.45% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.69% |
| Sharp | 0.82% | 1.02% |
| Beta | 0.9% | 0.79% |
| Alpha | -1.59% | 2.24% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Rohan Korde | Jay Kothari |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 20 |
| ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 5.53 | 20.83 |
| Large Cap | 30.13 | 17.17 |
| Mid Cap | 37.01 | 14.31 |
| Small Cap | 27.33 | 47.69 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 2.11 | 1.83 |
| Healthcare | 93.05 | 96.65 |
| Industrials | 1.04 | - |
| Financial Services | 1.35 | 1.52 |
| Basic Materials | 2.46 | - |
Top Comparisons
Nippon India Balanced Advantage Fund-Growth Plan-Bonus Option
3Y Returns%
Motilal Oswal Balance Advantage Fund (MOFDYNAMIC) - Regular Plan - Growth Option
3Y Returns6.78%
Mahindra Manulife Ultra Short Duration Fund - Regular Plan - Growth
3Y Returns6.9%
SBI Ultra Short Duration Fund - Regular Plan - Growth
3Y Returns7.04%
ICICI Prudential ELSS Tax Saver Fund (Tax Saving) - Growth
3Y Returns16.31%
Tata ELSS Fund - Regular Plan - Growth Option
3Y Returns15.86%
DSP Aggressive Hybrid Fund- Regular Plan - Growth
3Y Returns16.16%
Canara Robeco Equity Hybrid Fund - Regular Plan - Growth Option
3Y Returns13.86%